Knowledge, Attitudes and Practices Related to Medication, Antibiotics, and Vaccination among Public Service Population: National Survey Conducted in France
暂无分享,去创建一个
F. Carrouel | M. Lamure | C. Dussart | L. Fraticelli | Virginie-Eve Lvovschi | Benjamin du Sartz de Vigneulles | Geneviève Motyka
[1] E. Clays,et al. Polypharmacy and Health-Related Quality of Life/Psychological Distress Among Patients With Chronic Disease , 2022, Preventing chronic disease.
[2] Muhamad S. Aljeaidi,et al. Polypharmacy and trajectories of health-related quality of life in older adults: an Australian cohort study , 2022, Quality of Life Research.
[3] R. Rizzoli,et al. Prevalence of polypharmacy in community-dwelling older adults from seven centres in five European countries: a cross-sectional study of DO-HEALTH , 2022, BMJ Open.
[4] B. Sites,et al. Anxiolytic and sedative polypharmacy among US opioid users: a cross-sectional study , 2022, Regional Anesthesia & Pain Medicine.
[5] Toshiko Yamamoto,et al. Questionnaire-based survey on the prevalence of medication-overuse headache in Japanese one city—Itoigawa study , 2022, Neurological Sciences.
[6] Z. Hildon,et al. The Associations between Poor Antibiotic and Antimicrobial Resistance Knowledge and Inappropriate Antibiotic Use in the General Population Are Modified by Age , 2021, Antibiotics.
[7] T. Prell,et al. Factors Influencing Self-Reported Medication Use in the Survey of Health Aging and Retirement in Europe (SHARE) Dataset , 2021, Healthcare.
[8] C. Sprung,et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 , 2021, Intensive Care Medicine.
[9] W. Montelpare,et al. Predictors of Vaccine Hesitancy: Implications for COVID-19 Public Health Messaging , 2021, International journal of environmental research and public health.
[10] A. Ströhle,et al. COVID-19 vaccine hesitancy and related fears and anxiety , 2021, International Immunopharmacology.
[11] C. Sherbourne,et al. A Consensus-Based Checklist for Reporting of Survey Studies (CROSS) , 2021, Journal of General Internal Medicine.
[12] B. Kochar,et al. Emerging approaches to polypharmacy among older adults , 2021, Nature Aging.
[13] C. Tzourio,et al. Acceptance of a Covid-19 vaccine is associated with ability to detect fake news and health literacy , 2021, Journal of public health.
[14] R. Geneau. Pulling health promotion and chronic disease prevention from the margins of the global public health agenda-again. , 2021, Health promotion and chronic disease prevention in Canada : research, policy and practice.
[15] R. Rappuoli,et al. The role of vaccines in combatting antimicrobial resistance , 2021, Nature Reviews Microbiology.
[16] Amos Etzioni,et al. Adherence to Immunization: Rebuttal of Vaccine Hesitancy , 2020, Acta Haematologica.
[17] N. Rodondi,et al. What do older adults with multimorbidity and polypharmacy think about deprescribing? The LESS study - a primary care-based survey , 2020, BMC Geriatrics.
[18] E. Botelho-Nevers,et al. Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic , 2020, Vaccine.
[19] O. Okan,et al. COVID-19: health literacy is an underestimated problem , 2020, The Lancet Public Health.
[20] S. Voidăzan,et al. Knowledge, Attitudes And Practices Regarding The Use Of Antibiotics. Study On The General Population Of Mureş County, Romania , 2019, Infection and drug resistance.
[21] Satya Sivaraman,et al. Communication strategies for improving public awareness on appropriate antibiotic use: Bridging a vital gap for action on antibiotic resistance , 2019, Journal of family medicine and primary care.
[22] Joon-Hee Lee. Perspectives towards antibiotic resistance: from molecules to population , 2019, Journal of Microbiology.
[23] C. Stålsby Lundborg,et al. Drivers of Irrational Use of Antibiotics in Europe , 2018, International journal of environmental research and public health.
[24] P. Chauvin,et al. Who self-medicates? Results from structural equation modeling in the Greater Paris area, France , 2018, PloS one.
[25] N. Sartorius,et al. Trends of Polypharmacy and Prescription Patterns of Antidepressants in Asia , 2018, Journal of clinical psychopharmacology.
[26] P. Kardas,et al. Polypharmacy prevalence among older adults based on the survey of health, ageing and retirement in Europe. , 2018, Archives of gerontology and geriatrics.
[27] B. Golomb,et al. International Group for Reducing Inappropriate Medication Use & Polypharmacy (IGRIMUP): Position Statement and 10 Recommendations for Action , 2018, Drugs & Aging.
[28] C. Clements,et al. Relative toxicity of benzodiazepines and hypnotics commonly used for self-poisoning: An epidemiological study of fatal toxicity and case fatality , 2018, Journal of psychopharmacology.
[29] D. Stewart,et al. Benzodiazepine prescriptions and falls in older men and women , 2018 .
[30] W. Hryniewicz,et al. Surveys of public knowledge and attitudes with regard to antibiotics in Poland: Did the European Antibiotic Awareness Day campaigns change attitudes? , 2017, PloS one.
[31] M. Mittelmark,et al. The Handbook of Salutogenesis , 2017 .
[32] P. Denormandie,et al. Polypharmacy and potentially inappropriate medications: a cross-sectional analysis among 451 nursing homes in France , 2017, European Journal of Clinical Pharmacology.
[33] W. Welfare,et al. Active case finding for carbapenemase-producing Enterobacteriaceae in a teaching hospital: prevalence and risk factors for colonization. , 2016, The Journal of hospital infection.
[34] S. Waters. Suicide voices: testimonies of trauma in the French workplace , 2016, Medical Humanities.
[35] C. Pulcini,et al. Acceptability of antibiotic stewardship measures in primary care. , 2016, Medecine et maladies infectieuses.
[36] S. Mohile,et al. Polypharmacy and potentially inappropriate medication use in geriatric oncology. , 2016, Journal of geriatric oncology.
[37] Eileen M. Crimmins,et al. Lifespan and Healthspan: Past, Present, and Promise. , 2015, The Gerontologist.
[38] J. Chastang,et al. Working conditions and psychotropic drug use: cross-sectional and prospective results from the French national SIP study. , 2015, Journal of psychiatric research.
[39] C. L. Ventola,et al. The antibiotic resistance crisis: part 2: management strategies and new agents. , 2015, P & T : a peer-reviewed journal for formulary management.
[40] Onkar C. Swami,et al. Strategies to combat antimicrobial resistance. , 2014, Journal of clinical and diagnostic research : JCDR.
[41] E. C. Harris,et al. The role of mental health problems and common psychotropic drug treatments in accidental injury at work: a case–control study , 2014, Occupational and Environmental Medicine.
[42] H. Burr,et al. Does good leadership buffer effects of high emotional demands at work on risk of antidepressant treatment? A prospective study from two Nordic countries , 2014, Social Psychiatry and Psychiatric Epidemiology.
[43] Liang-Jen Wang,et al. Trends in anxiolytic-hypnotic use and polypharmacy in Taiwan, 2002-2009: a nationwide, population-based survey. , 2014, Psychiatric services.
[44] H. Allahverdipour,et al. Predictors of Self-Medication Behavior: A Systematic Review , 2014, Iranian journal of public health.
[45] Hans-Peter Grossart,et al. The multifaceted roles of antibiotics and antibiotic resistance in nature , 2013, Front. Microbiol..
[46] S. Rosman,et al. Gaining insight into benzodiazepine prescribing in General Practice in France: a data-based study , 2011, BMC family practice.
[47] Gilles Jeannot,et al. The Development and Current Features of the French Civil Service System , 2011 .
[48] H. Burr,et al. Person-related work and incident use of antidepressants: relations and mediating factors from the Danish work environment cohort study. , 2010, Scandinavian journal of work, environment & health.
[49] R. Rugulies,et al. Job stress and the use of antidepressant medicine: a 3.5-year follow-up study among Danish employees , 2010, Occupational and Environmental Medicine.
[50] S. L. C. da Silva,et al. Association between drug prescribing and quality of life in primary care , 2010, Pharmacy World & Science.
[51] É. Lavigne,et al. Psychosocial work environment, interpersonal violence at work and psychotropic drug use among correctional officers. , 2010, International journal of law and psychiatry.
[52] E. Agerbo,et al. Psychosocial work environment and antidepressant medication: a prospective cohort study , 2009, BMC public health.
[53] P. Böelle,et al. Significant Reduction of Antibiotic Use in the Community after a Nationwide Campaign in France, 2002–2007 , 2009, PLoS medicine.
[54] J. Fincham. Response Rates and Responsiveness for Surveys, Standards, and the Journal , 2008, American Journal of Pharmaceutical Education.
[55] C. Mcnulty,et al. Antimicrobial Drugs in the Home, United Kingdom , 2006, Emerging infectious diseases.
[56] C. Potter. Hesitancy , 2005 .
[57] J. Lépine,et al. The European Study of the Epidemiology of Mental Disorders (ESEMeD) project: an epidemiological basis for informing mental health policies in Europe , 2004, Acta psychiatrica Scandinavica. Supplementum.
[58] R. Kessler,et al. Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project , 2004, Acta psychiatrica Scandinavica. Supplementum.
[59] R. Gordon. An operational classification of disease prevention. , 1983, Public health reports.